| Veliparib |
ENSG00000031544.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000104691.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000157306.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000157306.10 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000157306.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000171671.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000175773.8 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000177337.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000177738.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000177853.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000178193.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000178193.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000179935.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000180139.10 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000180769.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000182021.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000182165.13 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000184068.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000185044.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000185837.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000185904.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000186019.10 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000186056.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000187904.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000187979.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000188660.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000188825.9 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000189223.9 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000189238.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000196553.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000196553.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000197332.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000198221.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000203288.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000203321.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000203327.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000203441.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000203496.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000203496.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000203497.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000203499.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000203588.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000203620.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000203709.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000203999.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000204044.5 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000204588.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000204625.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000204832.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000205500.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000205959.3 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000206028.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000206567.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000212552.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000213742.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000213742.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000213904.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000213963.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000213963.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000213963.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000213994.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000214293.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000214347.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000214401.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000214559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000214650.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000215023.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000215068.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000215068.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000215244.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000215424.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000215483.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000215692.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000215859.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000220161.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000223356.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000223380.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000223478.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000223478.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000223522.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000223522.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000223571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000223598.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000223598.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000223697.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000223704.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000223754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000223768.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000223791.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000223799.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000223842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000223855.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000223891.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000223901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000223923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000223946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000224020.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224037.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000224078.8 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000224157.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000224173.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000224174.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000224292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224342.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224409.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000224460.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000224490.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000224536.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000224597.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000224614.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000224635.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000224687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224746.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000224764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000224789.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000224790.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000224817.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000224818.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000224875.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000224897.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000224959.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000224961.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000224969.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000225039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000225039.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000225075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000225077.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000225092.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000225092.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000225111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000225187.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000225235.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000225361.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000225411.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000225527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000225532.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000225535.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000225595.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000225643.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000225703.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000225761.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000225778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000225793.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000225963.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000226044.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000226266.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000226310.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000226312.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000226383.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000226386.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000226445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000226476.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000226505.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000226516.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000226548.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000226609.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000226645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000226649.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000226686.3 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000226747.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000226756.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000226797.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000226800.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000226833.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000226842.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000226862.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000226876.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000226913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000227078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000227083.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000227279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227403.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000227409.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000227477.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227512.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000227512.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000227542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227543.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000227627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227719.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227726.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227726.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000227811.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000227811.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000227857.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000227877.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000227920.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000227953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000228022.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000228115.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000228124.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000228140.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000228203.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000228293.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000228317.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000228340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000228363.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000228395.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000228397.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000228408.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000228412.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000228436.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000228437.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000228463.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000228470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000228470.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000228527.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000228527.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000228634.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000228686.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000228786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000228791.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000228878.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000228886.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000228906.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000228933.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000228962.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000229081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000229118.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229122.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000229122.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000229154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000229190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000229190.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000229195.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000229311.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000229348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000229388.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000229589.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229688.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000229728.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000229750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000229832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000229869.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229873.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000229951.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229952.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000229955.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229980.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000229990.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000230002.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000230010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000230013.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000230013.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000230054.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000230068.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000230102.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000230177.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000230186.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000230257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000230289.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000230300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000230337.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000230423.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000230424.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000230433.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000230454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000230487.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000230542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000230565.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000230679.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000230684.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000230731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000230736.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000230899.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000230912.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000230914.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000231024.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231104.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000231105.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000231131.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000231193.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000231305.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000231305.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000231355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000231365.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000231412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000231419.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231429.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231439.3 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000231453.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000231486.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000231512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000231607.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000231636.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000231651.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000231663.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231704.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000231709.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000231776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000231830.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000231871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232085.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000232098.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000232139.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000232160.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000232300.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000232311.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000232342.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000232352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232453.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000232453.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000232470.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000232485.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000232545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000232628.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000232677.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000232686.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000232686.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000232732.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000232754.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000232759.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000232891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000232913.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000232936.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000232940.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000233006.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000233016.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000233016.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233060.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000233064.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000233070.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000233077.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000233080.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000233085.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233098.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233101.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000233108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000233110.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233203.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000233351.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000233452.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000233630.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000233665.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000233723.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000233775.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000233775.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000233845.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000233871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233878.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000233893.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000233895.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000233930.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000233937.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000233942.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234006.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000234028.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234129.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234155.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000234161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000234183.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000234232.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000234252.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000234281.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000234292.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234393.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000234453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000234650.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000234665.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000234676.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234689.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000234694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234705.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000234771.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000234793.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000234818.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000234832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000234900.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000234913.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000234915.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000234917.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000234943.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000234945.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000234978.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235078.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235092.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000235100.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235121.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235244.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000235262.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235314.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000235319.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000235381.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000235397.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235437.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235475.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000235481.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000235488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235495.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235497.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000235545.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235565.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000235586.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235615.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235641.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235641.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000235643.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000235659.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000235781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235790.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000235831.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000235852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000235908.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000235908.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235958.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000235989.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000236024.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000236066.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000236078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000236088.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000236088.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000236188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000236199.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236209.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000236234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000236256.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236345.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000236390.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000236423.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000236426.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000236426.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000236432.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236434.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000236498.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000236499.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000236519.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000236528.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000236559.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236581.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000236618.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000236703.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000236780.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000236869.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000236908.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000236914.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000236935.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000236986.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000237054.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000237133.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000237152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000237152.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000237250.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000237328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000237436.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000237438.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000237481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000237481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000237485.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000237513.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000237543.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000237614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000237646.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000237685.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000237718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000237786.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000237852.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000237857.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000237877.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000237927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000237938.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000237945.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000237945.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000238009.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000238009.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000238058.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000238058.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000238113.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000238141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000238141.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000239300.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000239407.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000239415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000239462.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000239552.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000239593.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000239608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000239608.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000239664.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000239674.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000239945.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000239945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000240005.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000240057.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000240497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000240758.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000240758.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000240766.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000241684.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000241732.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000241764.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000241818.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000241990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000242078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000242104.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000242147.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000242190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000242375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000242474.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000242759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000242767.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000242797.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000243055.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000243083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000243176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000243224.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000243243.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000243368.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000243415.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000243433.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000243701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000243701.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000244137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000244161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000244306.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000244332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000244675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000244945.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000244952.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000245112.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000245149.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000245293.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000245311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000245330.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000245522.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000245532.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000245573.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000245812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000245904.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246016.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246174.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000246214.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000246228.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246263.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000246273.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246323.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000246422.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000246422.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000246465.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000246523.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000246526.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000246548.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000246582.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000246582.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000246695.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246731.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000246863.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000246898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000247228.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000247228.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000247287.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000247324.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000247400.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000247679.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000247735.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000247934.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000247934.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000247950.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000248019.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000248027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000248175.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000248206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000248206.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000248294.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000248360.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000248544.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000248587.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000248597.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000248647.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000248663.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000248693.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000248719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000248858.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000248898.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000248925.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000248936.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000249084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000249084.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000249216.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000249234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000249234.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000249241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000249304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000249375.3 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000249417.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000249436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000249502.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000249572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000249574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000249593.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000249641.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000249650.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000249655.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000249664.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000249740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000249825.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000249868.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000250012.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000250049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000250061.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000250073.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000250075.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000250101.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000250122.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000250132.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000250133.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000250155.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000250159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000250159.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000250222.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000250240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000250259.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000250267.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000250312.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000250371.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000250548.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000250548.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000250602.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000250742.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000250742.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000250790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000250838.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000250900.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000250903.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000250917.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000250990.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000251003.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000251026.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000251129.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000251131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000251141.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000251151.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000251175.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000251292.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000251298.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000251350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000251350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000251396.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000251417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000251432.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000251555.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000251556.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000251586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000251600.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000251676.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000253112.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000253167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000253167.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000253187.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000253355.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000253392.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000253438.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000253562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000253582.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000253608.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000253616.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000253687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000253688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000253708.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000253716.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000253737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000253741.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000253819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000253825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000253848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000253875.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000253878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000253930.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254038.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000254142.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000254165.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000254233.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254258.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000254263.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254286.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000254340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000254350.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000254416.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254431.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000254461.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000254468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000254468.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254484.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254495.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000254495.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254495.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000254554.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000254560.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000254604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000254610.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000254682.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000254699.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000254739.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000254762.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000254812.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000254847.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000254854.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000254855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000254855.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000254910.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000254936.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000254990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000255031.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000255094.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000255129.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000255139.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000255145.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000255159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000255176.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000255176.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000255198.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000255201.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255202.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000255234.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000255241.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255247.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000255308.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255320.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000255320.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000255337.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000255355.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000255438.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000255443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000255443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000255455.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000255458.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000255467.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000255487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255487.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000255496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255517.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000255539.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000255557.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000255565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255741.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000255760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255893.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000255980.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000256050.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000256084.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000256116.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000256128.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000256139.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000256237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000256433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000256443.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000256458.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000256588.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000256588.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000256670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000256742.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000256789.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000256789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000256811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000256897.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000256973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000257004.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000257058.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000257167.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000257185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000257222.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000257270.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000257285.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000257346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000257354.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000257449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000257509.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000257515.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000257530.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000257543.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000257568.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000257588.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000257640.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000257647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000257681.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000257808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000257842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000257910.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000257964.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258044.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258057.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258077.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000258088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000258088.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000258096.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258122.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000258203.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000258274.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000258279.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000258303.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000258325.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000258334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000258334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000258378.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258378.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000258407.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000258414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258441.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258443.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258455.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000258458.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000258515.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258545.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000258553.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000258586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000258623.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000258711.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000258725.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000258752.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000258808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000258824.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000258920.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000258942.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000258952.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000258959.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259065.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000259088.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000259135.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000259206.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259206.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259212.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000259242.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000259343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000259354.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000259366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000259408.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000259457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000259469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000259488.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000259514.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259579.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259618.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259644.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259668.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000259668.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259682.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259687.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259694.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000259713.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259713.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259715.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259732.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259755.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000259760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000259763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000259767.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259773.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000259774.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000259783.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259788.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000259810.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259818.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259863.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000259867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000259877.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000259883.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000259894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000259933.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260000.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260017.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000260035.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260046.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260052.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260060.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000260063.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260081.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260132.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000260160.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000260167.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000260192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260194.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260252.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260252.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000260257.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000260260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260262.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260278.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260329.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000260352.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260360.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260360.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000260367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260368.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260369.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260396.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260396.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260400.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260418.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260418.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260470.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000260511.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260517.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260536.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260545.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000260577.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260589.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260601.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260601.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000260608.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260626.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260643.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260646.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260661.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260735.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260766.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000260790.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260803.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260814.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000260823.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000260831.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000260855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260877.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260877.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260911.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000260923.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260923.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000260971.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000260979.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000260988.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000261008.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000261015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261019.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261030.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261051.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261068.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261101.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000261123.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000261131.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000261159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261183.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000261183.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000261216.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261218.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261252.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000261252.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261253.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261286.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261334.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000261341.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000261369.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261369.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000261386.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261399.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000261404.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000261416.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261425.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261441.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000261468.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261474.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000261490.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000261512.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261533.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261550.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000261560.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000261572.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261589.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000261634.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261673.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000261690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261712.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000261729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261742.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000261775.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000261777.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261777.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261780.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000261804.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000261837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000261839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261842.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000261879.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000261971.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000262001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262074.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000262152.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000262228.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262298.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000262312.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000262313.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000262339.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262410.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000262410.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000262454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262482.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000262514.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000262521.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000262663.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000262681.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000262692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262714.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000262810.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262903.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000262905.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000262920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000262966.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000263011.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000263013.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000263164.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000263164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000263220.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000263470.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000263627.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000263709.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000263717.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000263895.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000264043.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000264188.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000264196.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000264235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000264235.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000264270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000264304.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000264548.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000264575.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000264608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000264630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000264829.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000264968.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000265010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000265055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000265394.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000265474.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000265478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000265496.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000265656.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000265749.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000265778.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000265845.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000265933.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000266010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000266079.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000266088.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000266278.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000266340.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000266368.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000266402.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000266446.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000266604.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000266717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000266744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000266824.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000266824.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000266850.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000266895.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000266927.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000266935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000266947.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000266947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000266968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000266970.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000266976.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000266983.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000266993.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267003.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267011.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000267025.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267026.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267063.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000267093.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267096.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267108.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000267143.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267151.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267169.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000267201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267212.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267244.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267251.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000267272.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267274.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267277.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000267322.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267347.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267348.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267366.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000267375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267381.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267388.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267388.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267397.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000267414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267440.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000267454.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267457.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000267479.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267530.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000267530.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000267557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000267567.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000267575.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267586.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000267638.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000267666.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000267711.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000267730.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267734.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267737.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000267745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000267745.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000267751.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000267778.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000267783.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000267798.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000268015.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000268027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000268119.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000268186.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000268189.2 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000268201.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000268204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000268364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000268499.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000268543.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000268549.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000268601.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000268658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000268670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000268802.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000268812.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000268812.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000269397.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000269463.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000269481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000269534.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000269640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000269688.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000269688.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000269806.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000269815.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000269834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000269843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000269896.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000269946.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000269947.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000269956.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000269961.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000269961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000269967.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000270006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000270018.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000270041.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000270097.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000270104.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000270108.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000270108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000270115.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000270117.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000270127.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000270140.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000270154.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000270154.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000270168.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000270210.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000270246.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000270332.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000270346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000270419.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000270419.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000270457.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000270571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000270604.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000270659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000270697.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000270720.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000270988.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000270996.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000271147.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000271199.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000271228.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000271270.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000271308.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271382.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000271384.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271576.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000271743.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000271751.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271803.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271815.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271821.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271825.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000271826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271835.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000271851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271855.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271862.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000271874.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271889.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000271963.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000271964.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000271967.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000271978.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000271991.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000271992.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000271996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272077.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272097.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272102.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272112.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272121.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272144.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000272144.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272146.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272180.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272203.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272217.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272221.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272221.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272254.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272275.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272282.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272354.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272374.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272375.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272375.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000272389.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272420.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272420.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272426.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272444.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000272457.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000272459.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272462.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272482.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272483.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272489.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272505.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272554.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272558.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272562.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272588.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272609.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272630.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272663.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272669.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272691.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000272695.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272716.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272717.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000272720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000272735.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000272746.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000272777.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272795.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000272800.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272859.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272861.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272864.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000272902.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000272902.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272911.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272912.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000272913.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000272914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000272917.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000272917.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000272931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000272949.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000273008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000273027.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000273032.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000273038.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000273061.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000273097.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Veliparib |
ENSG00000273117.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000273124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000273131.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000273133.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000273137.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000273156.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273164.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000273174.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000273183.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000273188.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273190.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273203.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Veliparib |
ENSG00000273209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000273209.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000273232.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000273245.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000273287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Veliparib |
ENSG00000273305.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000273306.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000273309.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Veliparib |
ENSG00000273338.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Veliparib |
ENSG00000273338.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273343.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
ENSG00000273350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000273366.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Veliparib |
ENSG00000273381.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Veliparib |
ENSG00000273381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Veliparib |
ENSG00000273437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000273443.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Veliparib |
ENSG00000273445.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000273447.1 |
Predicted lncRNA |
Sarcoma |
|
| Veliparib |
ENSG00000273451.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Veliparib |
PCAT-1 |
Curated lncRNA |
prostate cancer |
|